| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Summit Therapeutics Inc (NASDAQ: SMMT)
SMMT Technical Analysis
2
| As on 9th Jun 2023 SMMT STOCK Price closed @ 1.75 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.62 & Strong Sell for SHORT-TERM with Stoploss of 2.43 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SMMTSTOCK Price
| Open | 1.80 | Change | Price | % |
| High | 1.86 | 1 Day | -0.09 | -4.89 |
| Low | 1.74 | 1 Week | 0.12 | 7.36 |
| Close | 1.75 | 1 Month | 0.38 | 27.74 |
| Volume | 839502 | 1 Year | -0.70 | -28.57 |
| 52 Week High 5.41 | 52 Week Low 0.68 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SMMT Daily Charts |
SMMT Intraday Charts |
Whats New @ Bazaartrend |
SMMT Free Analysis |
|
|
SMMT Important Levels Intraday
| RESISTANCE | 1.98 |
| RESISTANCE | 1.91 |
| RESISTANCE | 1.86 |
| RESISTANCE | 1.82 |
| SUPPORT | 1.68 |
| SUPPORT | 1.64 |
| SUPPORT | 1.59 |
| SUPPORT | 1.52 |
SMMT Forecast May 2024
| 4th UP Forecast | 3.37 |
| 3rd UP Forecast | 2.85 |
| 2nd UP Forecast | 2.53 |
| 1st UP Forecast | 2.21 |
| 1st DOWN Forecast | 1.29 |
| 2nd DOWN Forecast | 0.97 |
| 3rd DOWN Forecast | 0.65 |
| 4th DOWN Forecast | 0.13 |
SMMT Weekly Forecast
| 4th UP Forecast | 2.93 |
| 3rd UP Forecast | 2.55 |
| 2nd UP Forecast | 2.32 |
| 1st UP Forecast | 2.08 |
| 1st DOWN Forecast | 1.42 |
| 2nd DOWN Forecast | 1.18 |
| 3rd DOWN Forecast | 0.95 |
| 4th DOWN Forecast | 0.57 |
SMMT Forecast2024
| 4th UP Forecast | 11.62 |
| 3rd UP Forecast | 8.45 |
| 2nd UP Forecast | 6.5 |
| 1st UP Forecast | 4.54 |
| 1st DOWN Forecast | -1.04 |
| 2nd DOWN Forecast | -3 |
| 3rd DOWN Forecast | -4.95 |
| 4th DOWN Forecast | -8.12 |
Summit Therapeutics Inc ( NASDAQ USA Symbol : SMMT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SMMT Business Profile
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also develops DDS-01 series to treat infection caused by the bacteria Neisseria gonorrhoeae through Discuva platform; and DDS-04 series to treat Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts. Address: One Broadway, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service